◼ Archived
Business
Novartis cites cases of previously unknown tumors possibly tied to its SMA gene therapy
Novartis reports cases of tumors in children following treatment with its spinal muscular atrophy gene therapy, Zolgensma.
2 trends tracked about this subject — the full history, oldest to newest below.
Novartis reports cases of tumors in children following treatment with its spinal muscular atrophy gene therapy, Zolgensma.
Congress has passed the ACT for ALS reauthorization act, advancing the bill to the president after legislative action.